跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
NOXAFIL posaconazole 300 mg/16.7 mL concentrated injection vial - TGA Drug Approval Details
Approvals
/
TGA
/
NOXAFIL posaconazole 300 mg/16.7 mL concentrated injection vial
Approved
STANDARD
NOXAFIL posaconazole 300 mg/16.7 mL concentrated injection vial
Merck Sharp & Dohme (Australia) Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
Dec 9, 2025
Approval ID
f8a911af8da17fd8
Company
Merck Sharp & Dohme (Australia) Pty Ltd
Type
Standard
Approval Details
Approval Id
f8a911af8da17fd8
Product Name
NOXAFIL posaconazole 300 mg/16.7 mL concentrated injection vial
Artg Id
218702
Artg Name
NOXAFIL posaconazole 300 mg/16.7 mL concentrated injection vial
Sponsor
Merck Sharp & Dohme (Australia) Pty Ltd
Company Detail Path
/organization/merck-sharp-and-dohme-australia-pty-ltd
Artg Date
2015-01-27
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/39051ae9c2604dd6e88e76a31a126084.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/f22c7eb70518f4b4aaaa9628c43ddb9a.pdf
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
Dec 9, 2025
Approval ID
f8a911af8da17fd8
Type
Standard
Back to TGA Approvals